Elderly: Clinical Trials

10 trials for Elderly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 2 recruiting, 1 not yet recruiting. 10 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 4, Unknown 3, Recruiting 2, Not yet recruiting 1
Phase 22Not yet recruiting 1, Unknown 1

Follow Elderly: new trials by email Literature Review of Elderly trials Research Report on Elderly

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
Intermediate-dose Cytarabine in Combination with Venetoclax - Acute Myeloid Leukemia (AML), Elderly
Phase 3RecruitingYehui Tan682025-06-012025-08-08
Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
edoxaban, Edoxaban 30 mg - Elderly, Atrial Fibrillation (AF)
Phase 2 / Phase 3Not yet recruitingNational Taiwan University Hospital3002025-04-012025-04-02
Sulodexide, VESSELĀ®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
Sulodexide, Sulodexide and placebo, Placebo - Venous Thromboembolism, Anticoagulant
Phase 3RecruitingArianna Anticoagulazione Foundation14552020-12-212024-07-31
Impact on General Functionality of an Immediate Prosthetic Functionalization Protocol in People Over 70 Years of Age With Deficient Removable Prostheses
prosthetic refunctioning, conventional prosthetic treatment - Removable Dental Prosthesis, Dental Restoration
Phase 3UnknownGerardo F Fasce Pineda, MD1082020-11-032022-10-26
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT
Decitabine, Busulfan (BU), Fludarabine(Flu) - Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University602018-06-152020-12-22
Long-term Study of FK949E in Elderly Bipolar Disorder Patients
FK949E - Bipolar Disorder, Elderly
Phase 3CompletedAstellas Pharma Inc202012-10-292024-11-19
Comparison of Medical Nutritional Supplements
Oral medical nutritional supplement, Experimental oral medical nutritional supplement with AN777 - Elderly
Phase 3CompletedAbbott Nutrition272011-10-012013-01-31
Evaluate Safety & Efficacy of Condroflex in Subjects With OA
condroflex and exercise, sugar pill and exercise - Treatment, Osteoarthritis
Phase 3UnknownZodiac Produtos Farmaceuticos S.A.2402009-03-012009-10-12
Weight Loss and Exercise in Physically Limited Obese Elderly Subjects
diet, exercise - Obesity, Frailty
Phase 3CompletedWashington University School of Medicine282003-01-012006-05-03
DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
DaunoXome, Daunorubicine - AML, Elderly
Phase 3CompletedGruppo Italiano Malattie EMatologiche dell'Adulto2001-10-012008-01-09

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Atrial Fibrillation (1)  ·  Bipolar Disorder (1)  ·  Frailty (1)  ·  Ischemic Stroke (1)  ·  Motor Activity (1)  ·  Obesity (1)  ·  Osteoarthritis (1)  ·  Venous Thromboembolism (1)  ·  Weight Loss (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Arrhythmias, Cardiac (1)  ·  Arthritis (1)  ·  Behavior (1)  ·  Bipolar and Related Disorders (1)  ·  Body Weight (1)

Interventions

Exercise (2)  ·  Busulfan (1)  ·  Daunorubicin (1)  ·  Decitabine (1)  ·  Diet (1)  ·  Quetiapine Fumarate (1)  ·  Sugars (1)  ·  edoxaban (1)  ·  glucuronyl glucosamine glycan sulfate (1)  ·  venetoclax (1)

Sponsors

Abbott Nutrition (1)  ·  Arianna Anticoagulazione Foundation (1)  ·  Astellas Pharma Inc (1)  ·  Gerardo F Fasce Pineda, MD (1)  ·  Gruppo Italiano Malattie EMatologiche dell'Adulto (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  National Taiwan University Hospital (1)  ·  Washington University School of Medicine (1)  ·  Yehui Tan (1)  ·  Zodiac Produtos Farmaceuticos S.A. (1)

Countries

China (2)  ·  United States (2)  ·  Brazil (1)  ·  Chile (1)  ·  Italy (1)  ·  Japan (1)  ·  Taiwan (1)

Top investigators

Corrado Lodigiani, MD,PhD (1)  ·  Dennis T Villareal, MD (1)  ·  Qifa Liu (1)  ·  Suely Roizenblatt (1)  ·  Vikkie Mustad, PhD (1)

Results publications

PMID 16636211, PMID 32451933, PMID 32792252, PMID 40831735

NIH funding

2019 (1)